Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Development of a foundation for a case definition of post-treatment Lyme disease syndrome.

Aucott JN, Crowder LA, Kortte KB.

Int J Infect Dis. 2013 Jun;17(6):e443-9. doi: 10.1016/j.ijid.2013.01.008. Epub 2013 Feb 23.

2.

Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?

Aucott JN, Rebman AW, Crowder LA, Kortte KB.

Qual Life Res. 2013 Feb;22(1):75-84.

3.

CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Bechtold KT.

Clin Vaccine Immunol. 2016 Sep 6;23(9):757-66. doi: 10.1128/CVI.00071-16. Print 2016 Sep.

4.

Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time.

Bechtold KT, Rebman AW, Crowder LA, Johnson-Greene D, Aucott JN.

Arch Clin Neuropsychol. 2017 Mar 1;32(2):129-141. doi: 10.1093/arclin/acw098.

PMID:
28365751
5.

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.

Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, Cooper D, Nadelman RB, Visintainer P, Schwartz I, Wormser GP.

Clin Infect Dis. 2015 Dec 15;61(12):1800-6. doi: 10.1093/cid/civ735. Epub 2015 Sep 18.

6.

Update of the Swiss guidelines on post-treatment Lyme disease syndrome.

Nemeth J, Bernasconi E, Heininger U, Abbas M, Nadal D, Strahm C, Erb S, Zimmerli S, Furrer H, Delaloye J, Kuntzer T, Altpeter E, Sturzenegger M, Weber R, For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology.

Swiss Med Wkly. 2016 Dec 5;146:w14353. doi: 10.4414/smw.2016.14353. eCollection 2016. Review.

7.

Posttreatment Lyme disease syndrome.

Aucott JN.

Infect Dis Clin North Am. 2015 Jun;29(2):309-23. doi: 10.1016/j.idc.2015.02.012. Review.

PMID:
25999226
8.

Subjective symptoms after treatment of early Lyme disease.

Cerar D, Cerar T, Ruzić-Sabljić E, Wormser GP, Strle F.

Am J Med. 2010 Jan;123(1):79-86. doi: 10.1016/j.amjmed.2009.05.011.

PMID:
20102996
9.

Health care costs, utilization and patterns of care following Lyme disease.

Adrion ER, Aucott J, Lemke KW, Weiner JP.

PLoS One. 2015 Feb 4;10(2):e0116767. doi: 10.1371/journal.pone.0116767. eCollection 2015.

10.

Functional outcomes in patients with Borrelia burgdorferi reinfection.

Jares TM, Mathiason MA, Kowalski TJ.

Ticks Tick Borne Dis. 2014 Feb;5(1):58-62. doi: 10.1016/j.ttbdis.2013.09.002. Epub 2013 Nov 9.

PMID:
24215678
11.

Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture.

Stupica D, Lusa L, Cerar T, Ružić-Sabljić E, Strle F.

Vector Borne Zoonotic Dis. 2011 Jul;11(7):883-9. doi: 10.1089/vbz.2010.0018. Epub 2010 Nov 17.

PMID:
21083376
12.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

Geebelen L, Lernout T, Kabamba-Mukadi B, Saegeman V, Sprong H, Van Gucht S, Beutels P, Speybroeck N, Tersago K.

Arch Public Health. 2017 Aug 7;75:42. doi: 10.1186/s13690-017-0202-z. eCollection 2017.

13.

Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease.

Steere AC, Dhar A, Hernandez J, Fischer PA, Sikand VK, Schoen RT, Nowakowski J, McHugh G, Persing DH.

Am J Med. 2003 Jan;114(1):58-62. No abstract available.

PMID:
12543291
14.

Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.

Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, Grunwaldt E, Agger WA, Franklin M, Oswald D, Cockey L, Maladorno D.

N Engl J Med. 1997 Jul 31;337(5):289-94.

15.

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans.

Luger SW, Paparone P, Wormser GP, Nadelman RB, Grunwaldt E, Gomez G, Wisniewski M, Collins JJ.

Antimicrob Agents Chemother. 1995 Mar;39(3):661-7.

16.

Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.

Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, Norton D, Levy L, Wall D, McCall J, Kosinski M, Weinstein A.

N Engl J Med. 2001 Jul 12;345(2):85-92.

17.

Treatment of erythema migrans with doxycycline for 10 days versus 15 days.

Stupica D, Lusa L, Ruzić-Sabljić E, Cerar T, Strle F.

Clin Infect Dis. 2012 Aug;55(3):343-50. doi: 10.1093/cid/cis402. Epub 2012 Apr 20.

PMID:
22523260
18.

An update on the diagnosis and treatment of early Lyme disease: "focusing on the bull's eye, you may miss the mark".

Stonehouse A, Studdiford JS, Henry CA.

J Emerg Med. 2010 Nov;39(5):e147-51. Epub 2007 Oct 18.

PMID:
17945460
19.

Long-term follow-up of patients with culture-confirmed Lyme disease.

Nowakowski J, Nadelman RB, Sell R, McKenna D, Cavaliere LF, Holmgren D, Gaidici A, Wormser GP.

Am J Med. 2003 Aug 1;115(2):91-6.

PMID:
12893393
20.

Lyme borreliosis in southern United Kingdom and a case for a new syndrome, chronic arthropod-borne neuropathy.

Dryden MS, Saeed K, Ogborn S, Swales P.

Epidemiol Infect. 2015 Feb;143(3):561-72. doi: 10.1017/S0950268814001071. Epub 2014 May 9.

PMID:
24814098

Supplemental Content

Support Center